Literature DB >> 17046105

High levels of hepatitis B virus DNA in body fluids from chronic carriers.

K Kidd-Ljunggren1, A Holmberg, J Bläckberg, B Lindqvist.   

Abstract

Chronic infection with hepatitis B virus (HBV) is a major global health problem. Transmission is mainly blood-borne, although the route of infection during horizontal transmission in childhood is unclear. Nosocomial outbreaks of HBV have been widely reported, but have mainly focused on blood-borne transmission. There is limited knowledge of the viral load levels in other body fluids. In the present study, chronic HBV carriers were tested for the presence of HBV DNA in serum, saliva, nasopharyngeal fluid, urine and tears by means of qualitative and quantitative polymerase chain reaction (PCR) methods. Twenty-five patients who were positive for HBV DNA with both PCRs were included. Low titres in real-time PCR corresponded with weak bands in the qualitative assay. HBV DNA was found in two urine samples, 10 saliva samples, five nasopharyngeal swabs and in tear fluid from four patients. One highly viraemic HBeAg-positive carrier with serum HBV DNA levels of 7 x 10(9) genome copies had high copy numbers detected in both saliva and nasopharyngeal fluid. These results demonstrate that highly viraemic HBV carriers may have high titres of HBV DNA in other body fluids. This has particular importance for infection control programmes and regulations, underlining the importance of aiming towards regular HBV DNA testing and thus infectivity assessment of chronic carriers in order to prevent transmission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046105     DOI: 10.1016/j.jhin.2006.06.029

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  25 in total

Review 1.  Tackling the Hepatitis B Disease Burden in India.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-12-15

2.  Clinical relevance and public health significance of hepatitis B virus genomic variations.

Authors:  Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

Review 3.  Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Mol Biol Rep       Date:  2020-12-09       Impact factor: 2.316

4.  Evaluation of Specificity and Sensitivity of Oral Fluid for Diagnosis of Hepatitis B.

Authors:  Smita V Khadse; Gunjan Bajaj; Pavitra Vibhakar; Purshotam Nainani; Rinky Ahuja; Gagan Deep
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 5.  Chronic hepatitis B in children and adolescents: epidemiology and management.

Authors:  Mona Abdel-Hady; Deirdre Kelly
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

Review 6.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

7.  [Experimental study on hepatitis B-virus X gene expression in adenoid cystic carcinoma].

Authors:  Ling Xie; Weihong Wang; Biao Xu; Yu Liu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2014-08

Review 8.  Update on hepatitis B and C virus diagnosis.

Authors:  Livia Melo Villar; Helena Medina Cruz; Jakeline Ribeiro Barbosa; Cristianne Sousa Bezerra; Moyra Machado Portilho; Letícia de Paula Scalioni
Journal:  World J Virol       Date:  2015-11-12

9.  Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin's lymphoma in an HBV carrier.

Authors:  Tomoki Aomatsu; Haruki Komatsu; Atsushi Yoden; Akiko Hosomi; Hiroshi Miyazaki; Tsuyoshi Sogo; Ayano Inui; Tomoo Fujisawa; Hiroshi Tamai
Journal:  Eur J Pediatr       Date:  2009-05-24       Impact factor: 3.183

10.  Infection Control Knowledge, Attitudes, and Practices among Students of Public Dental Schools in Egypt.

Authors:  Christina El-Saaidi; Omid Dadras; Patou Masika Musumari; Masako Ono-Kihara; Masahiro Kihara
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.